Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems.
Vijay Sagar MadamsettyReza MohammadinejadIlona UzielieneNoushin NabaviAli DehshahriJomarien García-CouceShima TavakolSaeid MoghassemiArezoo DadashzadehPooyan MakvandiAbbas PardakhtyAbbas Aghaei AfsharAli SeyfoddinPublished in: ACS biomaterials science & engineering (2022)
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19. However, DEX usage is often restricted in the clinic due to its poor water solubility. When administered through a systemic route, it can elicit severe side effects, such as hypertension, peptic ulcers, hyperglycemia, and hydro-electrolytic disorders. There is currently much interest in developing efficient DEX-loaded nanoformulations that ameliorate adverse disease effects inhibiting advancements in scientific research. Various nanoparticles have been developed to selectively deliver drugs without destroying healthy cells or organs in recent years. In the present review, we have summarized some of the most attractive applications of DEX-loaded delivery systems, including liposomes, polymers, hydrogels, nanofibers, silica, calcium phosphate, and hydroxyapatite. This review provides our readers with a broad spectrum of nanomedicine approaches to deliver DEX safely.
Keyphrases
- drug delivery
- cancer therapy
- wound healing
- high dose
- low dose
- sars cov
- induced apoptosis
- drug release
- primary care
- papillary thyroid
- signaling pathway
- cell cycle arrest
- emergency department
- early onset
- squamous cell carcinoma
- oxidative stress
- young adults
- tissue engineering
- optical coherence tomography
- hyaluronic acid
- pi k akt
- optic nerve